Formulary decisions: Then and now

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

An institution's formulary is a constantly evolving entity with a myriad of considerations that must be taken into account when any agent or chemical entity is being evaluated for formulary inclusion or is under review to continue as a therapeutic option. Originally a simple list of available agents, the formulary has developed into a required part of the hospital's administrative structure and an authoritative source for cost-effective management of drug use within the institution. In recent years, closer evaluations of internal processes surrounding drugs with black-box warnings, safety protocols, and the development of programs such as the risk evaluation and mitigation strategies (REMS) have added to the costs of using some therapeutic agents. Whether it is regulatory agencies levying fines for inappropriate use of a drug, the cost of compliance with various therapeutic protocols within an institution, or the costs of adhering to the requirements of REMS, formulary choices have a much greater impact on an institution's budget now than they did in the recent past. In the future, one may also see reduced or denied payments under increasingly recognized "never events," should they be applied specifically to a given drug or class of drugs. Forward-looking pharmacists must accept the challenge of making thoughtful formulary decisions within this complex milieu that extends well beyond assessment of cost-effectiveness focused on therapeutic efficacy and acquisition costs.

Original languageEnglish (US)
Pages (from-to)35S-41S
JournalPharmacotherapy
Volume30
Issue number6 PART 2
DOIs
StatePublished - Jun 1 2010

Fingerprint

Formularies
Costs and Cost Analysis
Pharmaceutical Preparations
Drug Labeling
Medical Errors
Drug Costs
Program Development
Budgets
Therapeutics
Pharmacists
Cost-Benefit Analysis
Safety

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Formulary decisions : Then and now. / Boucher, Bradley A.

In: Pharmacotherapy, Vol. 30, No. 6 PART 2, 01.06.2010, p. 35S-41S.

Research output: Contribution to journalReview article

Boucher, Bradley A. / Formulary decisions : Then and now. In: Pharmacotherapy. 2010 ; Vol. 30, No. 6 PART 2. pp. 35S-41S.
@article{7364d752b8d6490ba46f92c7443ab585,
title = "Formulary decisions: Then and now",
abstract = "An institution's formulary is a constantly evolving entity with a myriad of considerations that must be taken into account when any agent or chemical entity is being evaluated for formulary inclusion or is under review to continue as a therapeutic option. Originally a simple list of available agents, the formulary has developed into a required part of the hospital's administrative structure and an authoritative source for cost-effective management of drug use within the institution. In recent years, closer evaluations of internal processes surrounding drugs with black-box warnings, safety protocols, and the development of programs such as the risk evaluation and mitigation strategies (REMS) have added to the costs of using some therapeutic agents. Whether it is regulatory agencies levying fines for inappropriate use of a drug, the cost of compliance with various therapeutic protocols within an institution, or the costs of adhering to the requirements of REMS, formulary choices have a much greater impact on an institution's budget now than they did in the recent past. In the future, one may also see reduced or denied payments under increasingly recognized {"}never events,{"} should they be applied specifically to a given drug or class of drugs. Forward-looking pharmacists must accept the challenge of making thoughtful formulary decisions within this complex milieu that extends well beyond assessment of cost-effectiveness focused on therapeutic efficacy and acquisition costs.",
author = "Boucher, {Bradley A.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1592/phco.30.pt2.35S",
language = "English (US)",
volume = "30",
pages = "35S--41S",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "6 PART 2",

}

TY - JOUR

T1 - Formulary decisions

T2 - Then and now

AU - Boucher, Bradley A.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - An institution's formulary is a constantly evolving entity with a myriad of considerations that must be taken into account when any agent or chemical entity is being evaluated for formulary inclusion or is under review to continue as a therapeutic option. Originally a simple list of available agents, the formulary has developed into a required part of the hospital's administrative structure and an authoritative source for cost-effective management of drug use within the institution. In recent years, closer evaluations of internal processes surrounding drugs with black-box warnings, safety protocols, and the development of programs such as the risk evaluation and mitigation strategies (REMS) have added to the costs of using some therapeutic agents. Whether it is regulatory agencies levying fines for inappropriate use of a drug, the cost of compliance with various therapeutic protocols within an institution, or the costs of adhering to the requirements of REMS, formulary choices have a much greater impact on an institution's budget now than they did in the recent past. In the future, one may also see reduced or denied payments under increasingly recognized "never events," should they be applied specifically to a given drug or class of drugs. Forward-looking pharmacists must accept the challenge of making thoughtful formulary decisions within this complex milieu that extends well beyond assessment of cost-effectiveness focused on therapeutic efficacy and acquisition costs.

AB - An institution's formulary is a constantly evolving entity with a myriad of considerations that must be taken into account when any agent or chemical entity is being evaluated for formulary inclusion or is under review to continue as a therapeutic option. Originally a simple list of available agents, the formulary has developed into a required part of the hospital's administrative structure and an authoritative source for cost-effective management of drug use within the institution. In recent years, closer evaluations of internal processes surrounding drugs with black-box warnings, safety protocols, and the development of programs such as the risk evaluation and mitigation strategies (REMS) have added to the costs of using some therapeutic agents. Whether it is regulatory agencies levying fines for inappropriate use of a drug, the cost of compliance with various therapeutic protocols within an institution, or the costs of adhering to the requirements of REMS, formulary choices have a much greater impact on an institution's budget now than they did in the recent past. In the future, one may also see reduced or denied payments under increasingly recognized "never events," should they be applied specifically to a given drug or class of drugs. Forward-looking pharmacists must accept the challenge of making thoughtful formulary decisions within this complex milieu that extends well beyond assessment of cost-effectiveness focused on therapeutic efficacy and acquisition costs.

UR - http://www.scopus.com/inward/record.url?scp=77954170301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954170301&partnerID=8YFLogxK

U2 - 10.1592/phco.30.pt2.35S

DO - 10.1592/phco.30.pt2.35S

M3 - Review article

C2 - 20500042

AN - SCOPUS:77954170301

VL - 30

SP - 35S-41S

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 6 PART 2

ER -